Related references
Note: Only part of the references are listed.New method for rapid and dynamic quantification of elastase activity on sputum neutrophils from patients with cystic fibrosis using flow cytometry
Matthias Hagner et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis
Martina Oriano et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
James D. Chalmers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation
Amelia Shoemark et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis
Oriol Sibila et al.
THORAX (2019)
Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
Holly R. Keir et al.
ERJ OPEN RESEARCH (2019)
Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure-Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects
Robert Palmer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Patrick A. Flume et al.
LANCET (2018)
Bronchiectasis
James D. Chalmers et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
Adam T. Hill et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
European Respiratory Society guidelines for the management of adult bronchiectasis
Eva Polverino et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
An automated sampling importance resampling procedure for estimating parameter uncertainty
Anne-Gaelle Dosne et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2017)
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling
Anne-Gaelle Dosne et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2016)
Inflammatory Responses, Spirometry, and Quality of Life in Subjects With Bronchiectasis Exacerbations
Wei-jie Guan et al.
RESPIRATORY CARE (2015)
Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non-Cystic Fibrosis Bronchiectasis
James D. Chalmers et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Influence of DNA on the Activities and Inhibition of Neutrophil Serine Proteases in Cystic Fibrosis Sputum
Alice V. Dubois et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
Martin Bergstrand et al.
AAPS JOURNAL (2011)
Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century
Pieter Goeminne et al.
POSTGRADUATE MEDICAL JOURNAL (2010)
Mechanism-based concepts of size and maturity in pharmacokinetics
B. J. Anderson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models:: The npde add-on package for R
Emmanuelle Comets et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
Share Paper
